Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

Kobayashi, M. et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827–845 (1989)

Trinchieri, G. et al. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog. Growth Factor Res. 4, 355–368 (1992)

Leonard, J. P., Waldburger, K. E. & Goldman, S. J. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181, 381–386 (1995)

Issazadeh, S., Ljungdahl, A., Hojeberg, B., Mustafa, M. & Olsson, T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumour necrosis factor α and tumour necrosis factor β. J. Neuroimmunol. 61, 205–212 (1995)

Leonard, J. P., Waldburger, K. E. & Goldman, S. J. Regulation of experimental autoimmune encephalomyelitis by interleukin-12. Ann. NY Acad. Sci. 795, 216–226 (1996)

Constantinescu, C. S. et al. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J. Immunol. 161, 5097–5104 (1998)

Segal, B. M., Dwyer, B. K. & Shevach, E. M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187, 537–546 (1998)

Oppmann, B. et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715–725 (2000)

Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699–5708 (2002)

Wiekowski, M. T. et al. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility and premature death. J. Immunol. 166, 7563–7570 (2001)

Cua, D. J., Hutchins, B., LaFace, D. M., Stohlman, S. A. & Coffman, R. L. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 166, 602–608 (2001)

O'Garra, A. & Arai, N. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10, 542–550 (2000)

Caspi, R. R. IL-12 in autoimmunity. Clin. Immunol. Immunopathol. 88, 4–13 (1998)

Falcone, M. & Sarvetnick, N. Cytokines that regulate autoimmune responses. Curr. Opin. Immunol. 11, 670–676 (1999)

Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B. & Ramshaw, I. A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157, 3223–3227 (1996)

Chu, C. Q., Wittmer, S. & Dalton, D. K. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 123–128 (2000)

Matthys, P., Vermeire, K. & Billiau, A. Mac-1+ myelopoiesis induced by CFA: a clue to the paradoxical effects of IFN-γ in autoimmune disease models. Trends Immunol. 22, 367–371 (2001)

Hickey, W. F., Hsu, B. L. & Kimura, H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254–260 (1991)

Sedgwick, J. D. et al. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl Acad. Sci. USA 88, 7438–7442 (1991)

Frucht, D. M. IL-23: a cytokine that acts on memory T cells. Sci. STKE 114 (2002) pe1 [online] 〈 http://stke.sciencemag.org/ 〉 (2002)

Nguyen, K. B. et al. Critical role for STAT4 activation by type 1 interferons in the interferon-γ response to viral infection. Science 297, 2063–2066 (2002)

Chabas, D. et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294, 1731–1735 (2001)

Chen, Q. et al. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407, 916–920 (2000)

Pflanz, S. et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 16, 779–790 (2002)

Holscher, C. et al. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167, 6957–6966 (2001)

Piccotti, J. R. et al. Alloantigen-reactive Th1 development in IL-12-deficient mice. J. Immunol. 160, 1132–1138 (1998)

Becher, B., Durell, B. G. & Noelle, R. J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 110, 493–497 (2002)

Chen, S. C. et al. Impaired pulmonary host defense in mice lacking expression of the CXC chemokine lungkine. J. Immunol. 166, 3362–3368 (2001)

Hickey, W. F. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1, 97–105 (1991)